Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical Trial
A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention-Deficit/Hyperactivity Disorder; https://clinicaltrials.gov/study/NCT05257265 DIVERSITY & INCLUSION STATEMENT: We worked to ensure sex and gender balance in the recruitment of human participants. We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We worked to ensure that the study questionnaires were prepared in an inclusive way. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science. One or more of the authors of this paper self-identifies as living with a disability. We actively worked to promote sex and gender balance in our author group. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.
Authors
- Timothy E. Wilens (ORCID: https://orcid.org/0000-0002-5749-8503)
- Taisa Skubiak (ORCID: https://orcid.org/0009-0005-4396-2693)
- Ann Catherine Childress (ORCID: https://orcid.org/0000-0001-5782-7891)
- Osman Turkoglu
- Nini Jin
- Caroline Ward (ORCID: https://orcid.org/0000-0003-4857-7397)
Institutions
- Pharmaceutical Product Development (United States) (US)
- Otsuka (United States) (US)
- Massachusetts General Hospital (US)
- Center for Psychiatry and Behavioral Medicine (US)
Publication Details
- Journal
- Journal of the American Academy of Child & Adolescent Psychiatry
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1016/j.jaac.2025.06.023
- Citations
- 3
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 4.41
Funders
- Major League Baseball
- National Institutes of Health
- Otsuka Pharmaceutical Development and Commercialization
- National Institute on Drug Abuse